|
FAM188A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.44570000415456E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.51529999995004E-06 |
| Normal-vs-Stage2 |
3.55369999982535E-07 |
| Normal-vs-Stage3 |
1.23200338819629E-11 |
| Normal-vs-Stage4 |
5.37581090753747E-12 |
| Stage1-vs-Stage2 |
1.830180E-01 |
| Stage1-vs-Stage3 |
1.376870E-03 |
| Stage1-vs-Stage4 |
8.23500000000088E-05 |
| Stage2-vs-Stage3 |
3.058000E-01 |
| Stage2-vs-Stage4 |
8.476400E-02 |
| Stage3-vs-Stage4 |
4.032400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.87739992627701E-10 |
| Normal-vs-AfricanAmerican |
2.303200E-03 |
| Normal-vs-Asian |
1.87941999999497E-05 |
| Caucasian-vs-AfricanAmerican |
3.448600E-01 |
| Caucasian-vs-Asian |
2.288800E-01 |
| AfricanAmerican-vs-Asian |
8.474200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.68619953742211E-10 |
| Normal-vs-Female |
1.72530000286386E-08 |
| Male-vs-Female |
1.749180E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.70290000004003E-06 |
| Normal-vs-Age(41-60Yrs) |
2.81409995306348E-09 |
| Normal-vs-Age(61-80Yrs) |
1.11699538507537E-11 |
| Normal-vs-Age(81-100Yrs) |
7.021000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.891600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.401400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.385200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.067000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.753000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.491600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.309700E-02 |
| Classical-VS-Follicular |
9.901400E-01 |
| Classical-VS-Other |
6.260800E-01 |
| Classical-VS-Normal |
4.12749999734174E-08 |
| Tall-VS-Follicular |
1.947510E-02 |
| Tall-VS-Other |
2.725800E-01 |
| Tall-VS-Normal |
1.064800003725E-08 |
| Follicular-VS-Other |
6.321400E-01 |
| Follicular-VS-Normal |
1.58151999999356E-05 |
| Other-VS-Normal |
4.285200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.71080002678792E-09 |
| Normal-vs-N1 |
7.72300001727899E-09 |
| N0-vs-N1 |
2.100000E-01 |
|
|
